The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Predicting Diabetes: Clinical, Biological, and Genetic Approaches
Open accessAbstract
OBJECTIVE—To provide a simple clinical diabetes risk score and to identify characteristics that predict later diabetes using variables available in the clinic setting as well as biological variables and polymorphisms. RESEARCH DESIGN AND METHODS—Incident diabetes was studied in 1,863 men and 1,954 women, 30–65 years of age at baseline, with diabetes defined by treatment or by fasting plasma glucose ≥7.0 mmol/l at 3-yearly examinations over 9 years. Sex-specific logistic regression equations were used to select variables for prediction. RESULTS—A total of 140 men and 63 women developed diabetes. The predictive clinical variables were waist circumference and hypertension in both sexes, smoking in men, and diabetes in the family in women. Discrimination, as measured by the area under the receiver operating curves (AROCs), were 0.713 for men and 0.827 for women, a little higher than for the Finish Diabetes Risk (FINDRISC) score, with fewer variables in the score. Combining clinical and biological variables, the predictive equation included fasting glucose, waist circumference, smoking, and γ-glutamyltransferase for men and fasting glucose, BMI, triglycerides, and diabetes in family for women. The number of TCF7L2 and IL6 deleterious alleles was predictive in both sexes, but after including the above clinical and biological variables, this variable was only predictive in women (P < 0.03) and the AROC statistics increased only marginally. CONCLUSIONS—The best clinical predictor of diabetes is adiposity, and baseline glucose is the best biological predictor. Clinical and biological predictors differed marginally between men and women. The genetic polymorphisms added little to the prediction of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Active Smoking and the Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Willi, C., Bodenmann, P., Ghali, W. A., Faris, P. D., & Cornuz, J. (2007) · JAMA · doi:10.1001/jama.298.22.2654 · Cited by 1,268
Screening for type 2 diabetes: literature review and economic modelling
Waugh, N., Scotland, G., McNamee, P., Gillett, M., Brennan, A., Goyder, E., Williams, R., & John, A. (2007) · Health Technology Assessment · doi:10.3310/hta11170 · Cited by 298
Cited by
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551
Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00316-2 · Cited by 551
Collins, G. S., Mallett, S., Omar, O., & Yu, L.-M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-103 · Cited by 484
A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P., Lindström, J., Lalic, N., Greaves, C., McKee, M., Kissimova-Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 469
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept
for the D.E.S.I.R. Study Group, Amar, J., Serino, M., Lange, C., Chabo, C., Iacovoni, J., Mondot, S., Lepage, P., Klopp, C., Mariette, J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2329-8 · Cited by 327
Self-citationAbbasi, A., Peelen, L. M., Corpeleijn, E., van der Schouw, Y. T., Stolk, R. P., Spijkerman, A. M. W., van der A, D. L., Moons, K. G. M., Navis, G., Bakker, S. J. L., et al. (2012) · BMJ · doi:10.1136/bmj.e5900 · Cited by 321
Chen, L., Magliano, D. J., Balkau, B., Colagiuri, S., Zimmet, P. Z., Tonkin, A. M., Mitchell, P., Phillips, P. J., & Shaw, J. E. (2010) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03478.x · Cited by 308
Self-citationRisk assessment tools for identifying individuals at risk of developing type 2 diabetes
Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq019 · Cited by 297
“Only a small number of single nucleotide polymorphisms were tested in 2 of these studies, yielding no improvement in discrimination of type 2 diabetes beyond noninvasively measured characteristics (55, 79).”
BackgroundMethodInfluentialPredictive models for diabetes mellitus using machine learning techniques
Lai, H., Huang, H., Keshavjee, K., Guergachi, A., & Gao, X. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0436-6 · Cited by 293
Chen, L., Magliano, D. J., Balkau, B., Colagiuri, S., Zimmet, P. Z., Tonkin, A. M., Mitchell, P., Phillips, P. J., & Shaw, J. E. (2010) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03507.x · Cited by 287
Self-citationDevelopment of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
Makrilakis, K., Liatis, S., Grammatikou, S., Perrea, D., Stathi, C., Tsiligros, P., & Katsilambros, N. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.006 · Cited by 199
Dairy Consumption and the Incidence of Hyperglycemia and the Metabolic Syndrome
Fumeron, F., Lamri, A., Abi Khalil, C., Jaziri, R., Porchay-Baldérelli, I., Lantieri, O., Vol, S., Balkau, B., Marre, M., & the Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study Group (2011) · Diabetes Care · doi:10.2337/dc10-1772 · Cited by 167
Self-citationLow Water Intake and Risk for New-Onset Hyperglycemia
Roussel, R., Fezeu, L., Bouby, N., Balkau, B., Lantieri, O., Alhenc-Gelas, F., Marre, M., Bankir, L., & for the D.E.S.I.R. Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0652 · Cited by 165
Self-citationZhang, L., Zhang, Z., Zhang, Y., Hu, G., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097865 · Cited by 130
Rancière, F., Botton, J., Slama, R., Lacroix, M. Z., Debrauwer, L., Charles, M. A., Roussel, R., Balkau, B., Magliano, D. J., & the D.E.S.I.R. Study Group (2019) · Environmental Health Perspectives · doi:10.1289/ehp5159 · Cited by 127
Self-citationThériault, S., Dina, C., Messika-Zeitoun, D., Le Scouarnec, S., Capoulade, R., Gaudreault, N., Rigade, S., Li, Z., Simonet, F., Lamontagne, M., et al. (2019) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.119.002617 · Cited by 90
Self-citationde Lauzon-Guillain, B., Fournier, A., Fabre, A., Simon, N., Mesrine, S., Boutron-Ruault, M.-C., Balkau, B., & Clavel-Chapelon, F. (2009) · Diabetologia · doi:10.1007/s00125-009-1456-y · Cited by 86
Self-citationLin, J.-W., Chang, Y.-C., Li, H.-Y., Chien, Y.-F., Wu, M.-Y., Tsai, R.-Y., Hsieh, Y.-C., Chen, Y.-J., Hwang, J.-J., & Chuang, L.-M. (2009) · Diabetes Care · doi:10.2337/dc09-0694 · Cited by 60
“Ten currently available DRSs, including the ARIC (Atherosclerosis Risk in Community Study), Asian Indian, Cambridge (UK), Danish, DESIR (Data from the Epidemiological Study on Insulin Resistance Syndrome) (French), Dutch, FINDRISC (Finnish), Oman, QDScore (UK), and Thai risk scores were analyzed (3-12).”
MethodAbbasi, A., Corpeleijn, E., Gansevoort, R. T., Gans, R. O. B., Struck, J., Schulte, J., Hillege, H. L., van der Harst, P., Stolk, R. P., Navis, G., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3278-9 · Cited by 27
Metadata
- Authors
- Balkau, B., Lange, C., Fezeu, L., Tichet, J., de Lauzon-Guillain, B., Czernichow, S., Fumeron, F., Froguel, P., Vaxillaire, M., Cauchi, S., Ducimetière, P., & Eschwège, E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-10-01
- Volume
- 31
- Issue
- 10
- Pages
- 2056-2061
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2096672909
- Cited by
- 246
- References
- 2
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.